FT
BioNTech and Pfizer raise hopes with breakthrough Covid-19 vaccine
Results from the phase 3 trials sent markets soaring on renewed hopes for an effective vaccine
Results from the phase 3 trials sent markets soaring on renewed hopes for an effective vaccine